Wells Fargo & Company MN Grows Stock Holdings in Allogene Therapeutics, Inc. (NASDAQ:ALLO)
Wells Fargo & Company MN lifted its stake in Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 29.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 104,593 shares of the company’s stock after purchasing an additional 23,779 shares during the period. Wells Fargo & Company MN’s holdings in Allogene Therapeutics were worth $223,000 […]
